Related references
Note: Only part of the references are listed.An assessment of the variation in the concentration of acetylcysteine in infusions for the treatment of paracetamol overdose
George P. Bailey et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning
Anselm Wong et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized trial
T. Pawelczyk et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2017)
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Christoph U. Correll et al.
WORLD PSYCHIATRY (2017)
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis
Christoph U. Correll et al.
ANNALS OF GENERAL PSYCHIATRY (2017)
N-Acetylcysteine in the Treatment of Craving in Substance Use Disorders: Systematic Review and Meta-Analysis
Michel Silvio Duailibi et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
N-Acetylcysteine in Depressive Symptoms and Functionality: A Systematic Review and Meta-Analysis
Brisa S. Fernandes et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study
Eduardo Prado et al.
REDOX REPORT (2015)
N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review
Georgina Oliver et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2015)
A Meta-Analysis of Oxidative Stress Markers in Depression
Tao Liu et al.
PLOS ONE (2015)
The Efficacy of Adjunctive N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial
Michael Berk et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Edward Chesney et al.
WORLD PSYCHIATRY (2014)
Meta-Analysis of Oxidative Stress in Schizophrenia
Joshua Flatow et al.
BIOLOGICAL PSYCHIATRY (2013)
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Mehdi Farokhnia et al.
CLINICAL NEUROPHARMACOLOGY (2013)
N-Acetylcysteine Augmentation to Tranylcypromine in Treatment-Resistant Major Depression
André F. Carvalho et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
The promise of N-acetylcysteine in neuropsychiatry
Michael Berk et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice
Ilhem Amrouche-Mekkioui et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
The relevance of oxidative stress status in first episode and recurrent depression
Cristinel Stefanescu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature
Rebecca E. Anglin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages
J. R. Palacio et al.
INFLAMMATION RESEARCH (2011)
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial
Michael Berk et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Olivia Dean et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
N-acetyl Cysteine Treatment Rescues Cognitive Deficits Induced by Mitochondrial Dysfunction in G72/G30 Transgenic Mice
David-Marian Otte et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Oxidation of Plasma Cysteine/Cystine Redox State in Endotoxin-Induced Lung Injury
Smita S. Iyer et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania A Double-blind, Placebo-Controlled Study
Jon E. Grant et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
Jun-Feng Wang et al.
BIPOLAR DISORDERS (2009)
Reactive Oxygen Species-Induced Cell Death of Rat Primary Astrocytes Through Mitochondria-Mediated Mechanism
Chia-Chun Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment
Birgul Elbozan Cumurcu et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia
Mahmut Bulut et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
N-acetyl cysteine for depressive symptoms in bipolar disorder - A double-blind randomized placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia
Mauricio Kunz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
The cystine/cysteine cycle:: a redox cycle regulating susceptibility versus resistance to cell death
A. Banjac et al.
ONCOGENE (2008)
S-Nitrosothiols signal hypoxia-mimetic vascular pathology
Lisa A. Palmer et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics
XY Zhang et al.
SCHIZOPHRENIA RESEARCH (2006)
Molecular evidence for mitochondrial dysfunction in bipolar disorder
C Konradi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Glutathione pathways in the brain
R Dringen et al.
BIOLOGICAL CHEMISTRY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)